Thursday, February 4, 2016

Viacyte

Viacyte, Inc. – First in Kind Cellular Treatment for Diabetes

Viacyte, Inc. – First in Kind Cellular Treatment for Diabetes

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell ...

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell ...

VC-01 Diabetes Therapy – Viacyte, Inc.

VC-01 Diabetes Therapy – Viacyte, Inc.

Company Overview – Viacyte, Inc.

Company Overview – Viacyte, Inc.

ViaCyte - Company Presentation - YouTube

ViaCyte - Company Presentation - YouTube

ViaCyte Announces Second Clinical Trial Site at University of ...

ViaCyte Announces Second Clinical Trial Site at University of ...

Stem Cell Engineering – Viacyte, Inc.

Stem Cell Engineering – Viacyte, Inc.

ViaCyte Encapsulation Trial - JDRF

ViaCyte Encapsulation Trial - JDRF

California Stem Cell Report: $55 Million California ...

California Stem Cell Report: $55 Million California ...

Photos | SanDiegoUnionTribune.com

Photos | SanDiegoUnionTribune.com

Services - ViaCyte, Inc. - Pharmatching.com

Services - ViaCyte, Inc. - Pharmatching.com

Research | A Sweet Life

Research | A Sweet Life

Stocks Targeting Stem Cell and Related Therapies for Diabetes ...

Stocks Targeting Stem Cell and Related Therapies for Diabetes ...

Encaptra® Drug Delivery System – Viacyte, Inc.

Encaptra® Drug Delivery System – Viacyte, Inc.

Historic Progress for JDRF Encapsulation Research Program ...

Historic Progress for JDRF Encapsulation Research Program ...

Beta Cell Breakthroughs: Diabetes Forecast®

Beta Cell Breakthroughs: Diabetes Forecast®

In the news – Viacyte, Inc.

In the news – Viacyte, Inc.

No comments:

Post a Comment